Latest News & Updates

Breaking News

  • 2 hours ago

  • Vaibhavi M.

Artelo Biosciences Expands ART27.13 Into GLP-1 Therapy Market For Muscle Preservation, Backed by Trials And New Patent
Breaking News
Oragenics Issues Regulatory Notice On Audit Opinion Highlighting Going Concern Risk

Vaibhavi M.

Other trending news you may like to read

Artelo Biosciences Expands ART27.13 Into GLP-1 Therapy Market For Muscle Preservation, Backed by Trials And New Patent

Artelo expands ART27.13 into GLP-1 therapy market for muscle preservation, supported by CAReS trial data and a new patent targeting muscle loss in metabolic and obesity treatments.

Vaibhavi M.

Pharma Now

Oragenics Issues Regulatory Notice On Audit Opinion Highlighting Going Concern Risk

Oragenics reports going concern warning in FY2025 audit, disclosed under NYSE rules, highlighting financial risk while confirming no changes to previously filed financial statements.

Vaibhavi M.

Pharma Now

Thermo Fisher And SHL Medical Partner To Build Integrated Autoinjector And Sterile Manufacturing Hub In The U.S.

Thermo Fisher partners with SHL Medical to expand Ridgefield site, integrating Molly autoinjector assembly with sterile fill-finish manufacturing for drug-device products in chronic diseases.

Vaibhavi M.

Pharma Now

Recursion Appoints Oncology Veteran Vicki Goodman As Chief Medical Officer To Drive Clinical Strategy

Recursion appoints Vicki Goodman as Chief Medical Officer to lead clinical strategy, strengthen oncology development capabilities, and support pipeline advancement and upcoming regulatory milestones.

Vaibhavi M.

Pharma Now